We are live on ! Find out more
CAS

CTC Alternative Strategies Portfolio holdings

AUM $44M
1-Year Est. Return 43.15%
This Fund
S&P 500
This Quarter Est. Return
+13.62%
1 Year Est. Return
+43.15%
3 Year Est. Return
+76.07%
5 Year Est. Return
10 Year Est. Return
AUM
$160M
AUM Growth
+$112M
Cap. Flow
+$102M
Cap. Flow %
63.7%
Top 10 Hldgs %
78.69%
Holding
196
New
123
Increased
4
Reduced
2
Closed
67

Sector Composition

Rank Sector Weight
1 Energy 5.34%
2 Industrials 4.18%
3 Financials 4.18%
4 Consumer Discretionary 3.42%
5 Technology 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SACH
101
Sachem Capital Corp
SACH
$39.8M
$60.2K 0.04%
+13,500
New +$52K
GOEV
102
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$58.5K 0.04%
+820
New +$57.1K
KOPN icon
103
Kopin
KOPN
$791M
$58.5K 0.04%
+32,522
New +$72.2K
GOSS icon
104
Gossamer Bio
GOSS
$87M
$58.4K 0.04%
+49,500
New +$54.5K
NNBR icon
105
NN Inc
NNBR
$311M
$58.3K 0.04%
+12,300
New +$56.5K
ELEV
106
DELISTED
Elevation Oncology
ELEV
$56.9K 0.04%
+11,100
New +$36K
LNAI
107
Lunai Bioworks
LNAI
$10.9M
$56.7K 0.04%
+268
New +$72.3K
AXTI icon
108
AXT Inc
AXTI
$5.8B
$56.5K 0.04%
+12,300
New +$41.8K
BDTX icon
109
Black Diamond Therapeutics
BDTX
$112M
$55.8K 0.03%
+11,000
New +$44.4K
AIOT
110
PowerFleet Inc
AIOT
$592M
$54.5K 0.03%
+10,200
New +$34.5K
RGTI icon
111
Rigetti Computing
RGTI
$5.99B
$54.3K 0.03%
+35,500
New +$51.2K
RGLS
112
DELISTED
Regulus Therapeutics
RGLS
$53.3K 0.03%
+18,500
New +$30.2K
CBIO
113
Crescent Biopharma
CBIO
$626M
$53.1K 0.03%
+177
New +$52.9K
CIM
114
Chimera Investment
CIM
$1B
$52.1K 0.03%
+3,767
New +$52.5K
GTHX
115
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$51.8K 0.03%
+12,000
New +$41.8K
REKR icon
116
Rekor Systems
REKR
$91.7M
$51.1K 0.03%
+22,300
New +$61.5K
FREE
117
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$48.3K 0.03%
+10,000
New +$42.6K
ADTH
118
DELISTED
AdTheorent Holding Co
ADTH
$47.8K 0.03%
+14,900
New +$40.8K
SCLX icon
119
Scilex Holding
SCLX
$48.9M
$45.6K 0.03%
+820
New +$47.8K
ALTO icon
120
Alto Ingredients
ALTO
$340M
$45.1K 0.03%
+20,700
New +$43.6K
ABOS icon
121
Acumen Pharmaceuticals
ABOS
$176M
$45K 0.03%
+11,100
New +$41.8K
STXS icon
122
Stereotaxis
STXS
$141M
$43.3K 0.03%
+16,600
New +$39.5K
LVO icon
123
LiveOne
LVO
$58.2M
$41.7K 0.03%
+2,140
New +$34K
CTMX icon
124
CytomX Therapeutics
CTMX
$754M
$41.2K 0.03%
+18,900
New +$34.9K
PXLW icon
125
Pixelworks
PXLW
$41.6M
$41K 0.03%
+1,325
New +$35.1K

Similar funds

CTC Alternative Strategies's Q1 2024 Portfolio in Review

As of Q1 2024, CTC Alternative Strategies held 196 positions worth $160M, up 233% from $48.2M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

CTC Alternative Strategies deployed $102M of net new capital in Q1 2024, opening 123 new positions and adding to 4 existing holdings. Its largest new stake was iShares TIPS Bond ETF: 228,000 shares worth $24.5M.

By sector, the portfolio is most concentrated in Energy at 5.3% of assets, up from 0% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Erie Indemnity, an estimated $511K trimmed.

  • CTC Alternative Strategies's largest Q1 2024 buy was iShares TIPS Bond ETF: 228,000 shares worth $24.5M.
  • CTC Alternative Strategies added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2024, an estimated $21.2M increase.
  • CTC Alternative Strategies's biggest Q1 2024 reduction was Erie Indemnity, cutting an estimated $511K.
  • CTC Alternative Strategies fully exited RPT Realty Common Shares of Beneficial Interest (MD) in Q1 2024, selling an estimated $2.97M.
  • CTC Alternative Strategies's ten largest holdings make up 79% of its $160M portfolio in Q1 2024.
  • CTC Alternative Strategies opened 123 new positions and closed 67 in Q1 2024.
  • CTC Alternative Strategies's portfolio value rose 233% quarter-over-quarter to $160M.

Based on CTC Alternative Strategies's 13F filing for Q1 2024, filed 9 May 2024.